Jane Street
PCRX icon

Jane Street’s Pacira BioSciences PCRX Stock Holding History

Jane Street’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,600
Closed -$352K – 12631
2025
Q4 		$352K Buy
13,600
+4,700
+53% +$112K ﹤0.01% 8474
2025
Q3 		$229K Buy
+8,900
New +$219K ﹤0.01% 9412
2025
Q1 		– Sell
-91,600
Closed -$1.73M – 10317
2024
Q4 		$1.73M Buy
91,600
+9,600
+12% +$169K ﹤0.01% 4387
2024
Q3 		$1.23M Buy
82,000
+40,000
+95% +$684K ﹤0.01% 5457
2024
Q2 		$1.2M Buy
+42,000
New +$1.2M ﹤0.01% 5429
2023
Q3 		– Sell
-10,500
Closed -$421K – 9177
2023
Q2 		$421K Buy
10,500
+400
+4% +$16.5K ﹤0.01% 6585
2023
Q1 		$412K Buy
+10,100
New +$402K ﹤0.01% 6657
2022
Q4 		– Sell
-4,800
Closed -$255K – 9870
2022
Q3 		$255K Buy
+4,800
New +$267K ﹤0.01% 7825
2022
Q2 		– Sell
-4,000
Closed -$305K – 10550
2022
Q1 		$305K Sell
4,000
-600
-13% -$40K ﹤0.01% 8376
2021
Q4 		$277K Sell
4,600
-21,400
-82% -$1.18M ﹤0.01% 8327
2021
Q3 		$1.46M Buy
+26,000
New +$1.5M ﹤0.01% 5132
2021
Q2 		– Sell
-4,900
Closed -$343K – 10236
2021
Q1 		$343K Sell
4,900
-15,300
-76% -$1.09M ﹤0.01% 7487
2020
Q4 		$1.21M Buy
+20,200
New +$1.18M ﹤0.01% 4354
2020
Q3 		– Sell
-12,400
Closed -$651K – 7720
2020
Q2 		$651K Buy
+12,400
New +$518K ﹤0.01% 4679
2018
Q3 		– Sell
-33,900
Closed -$1.09M – 5552
2018
Q2 		$1.09M Buy
+33,900
New +$1.17M ﹤0.01% 2646
2017
Q2 		– Sell
-55,000
Closed -$2.51M – 4726
2017
Q1 		$2.51M Buy
+55,000
New +$2.38M 0.01% 1170

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's PCRX Position: Q1 2026 in Review

Jane Street reduced its Pacira BioSciences (PCRX) stake by 64% in Q1 2026, selling an estimated $5.46M and leaving 140,247 shares worth $3.17M. The position accounts for ﹤0.01% of the portfolio, ranked #4249.

Jane Street first reported a position in PCRX in Q1 2014 and has held it in 38 quarters since. The position peaked at $9.99M in Q4 2025. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

  • Jane Street held 140,247 shares of Pacira BioSciences worth $3.17M as of Q1 2026.
  • Jane Street sold 245,737 Pacira BioSciences shares in Q1 2026, an estimated $5.46M.
  • Pacira BioSciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4249 holding.
  • Jane Street first reported a position in Pacira BioSciences in Q1 2014 and has held it in 38 quarters since.
  • Jane Street's Pacira BioSciences position peaked at $9.99M in Q4 2025.
  • 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.